227 related articles for article (PubMed ID: 18408225)
1. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma.
Zhang Y; Sanjose SD; Bracci PM; Morton LM; Wang R; Brennan P; Hartge P; Boffetta P; Becker N; Maynadie M; Foretova L; Cocco P; Staines A; Holford T; Holly EA; Nieters A; Benavente Y; Bernstein L; Zahm SH; Zheng T
Am J Epidemiol; 2008 Jun; 167(11):1321-31. PubMed ID: 18408225
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
3. Personal use of hair dyes--increased risk of non-Hodgkin's lymphoma in Thailand.
Sangrajrang S; Renard H; Kuhaprema T; Pornsopone P; Arpornwirat W; Brennan P
Asian Pac J Cancer Prev; 2011; 12(9):2393-6. PubMed ID: 22296389
[TBL] [Abstract][Full Text] [Related]
4. Association between personal use of hair dyes and lymphoid neoplasms in Europe.
de Sanjosé S; Benavente Y; Nieters A; Foretova L; Maynadié M; Cocco PL; Staines A; Vornanen M; Boffetta P; Becker N; Alvaro T; Brennan P
Am J Epidemiol; 2006 Jul; 164(1):47-55. PubMed ID: 16731576
[TBL] [Abstract][Full Text] [Related]
5. Personal use of hair dyes and hematolymphopoietic malignancies.
Miligi L; Costantini AS; Benvenuti A; Veraldi A; Tumino R; Ramazzotti V; Vindigni C; Amadori D; Fontana A; Rodella S; Stagnaro E; Crosignani P; Vineis P
Arch Environ Occup Health; 2005; 60(5):249-56. PubMed ID: 17290845
[TBL] [Abstract][Full Text] [Related]
6. Insecticide use and risk of non-Hodgkin lymphoma subtypes: A subset meta-analysis of the North American Pooled Project.
Kachuri L; Beane Freeman LE; Spinelli JJ; Blair A; Pahwa M; Koutros S; Hoar Zahm S; Cantor KP; Weisenburger DD; Pahwa P; Dosman JA; McLaughlin JR; Demers PA; Harris SA
Int J Cancer; 2020 Dec; 147(12):3370-3383. PubMed ID: 32574374
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.
Zhang Y; Hughes KJ; Zahm SH; Zhang Y; Holford TR; Dai L; Bai Y; Han X; Qin Q; Lan Q; Rothman N; Zhu Y; Leaderer B; Zheng T
Am J Epidemiol; 2009 Nov; 170(10):1222-30. PubMed ID: 19822571
[TBL] [Abstract][Full Text] [Related]
10. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph [correction of IinterLlymph] analysis.
Cocco P; Vermeulen R; Flore V; Nonne T; Campagna M; Purdue M; Blair A; Monnereau A; Orsi L; Clavel J; Becker N; de Sanjosé S; Foretova L; Staines A; Maynadié M; Nieters A; Miligi L; 't Mannetje A; Kricker A; Brennan P; Boffetta P; Lan Q; Rothman N
Occup Environ Med; 2013 Nov; 70(11):795-802. PubMed ID: 23881218
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes.
Purdue MP; Lan Q; Langseth H; Grimsrud TK; Hildesheim A; Rothman N
Int J Cancer; 2020 Jun; 146(12):3312-3319. PubMed ID: 31523805
[TBL] [Abstract][Full Text] [Related]
12. Occupational risk factors for subgroups of non-Hodgkin's lymphoma.
Tatham L; Tolbert P; Kjeldsberg C
Epidemiology; 1997 Sep; 8(5):551-8. PubMed ID: 9270958
[TBL] [Abstract][Full Text] [Related]
13. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A
Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796
[TBL] [Abstract][Full Text] [Related]
14. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
[TBL] [Abstract][Full Text] [Related]
15. Regular use of hair dyes and risk of lymphoma in Spain.
Benavente Y; Garcia N; Domingo-Domenech E; Alvaro T; Font R; Zhang Y; de Sanjose S
Int J Epidemiol; 2005 Oct; 34(5):1118-22. PubMed ID: 15914502
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
17. A Meta-Analysis on the Relationship Between Hair Dye and the Incidence of Non-Hodgkin's Lymphoma.
Qin L; Deng HY; Chen SJ; Wei W
Med Princ Pract; 2019; 28(3):222-230. PubMed ID: 30583293
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
19. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
Morton LM; Bernstein L; Wang SS; Hein DW; Rothman N; Colt JS; Davis S; Cerhan JR; Severson RK; Welch R; Hartge P; Zahm SH
Carcinogenesis; 2007 Aug; 28(8):1759-64. PubMed ID: 17522066
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]